Whistleblower Must Show Pfizer Provided Kickbacks In Off-Label Promotion
Executive Summary
A former Pharmacia & Upjohn executive may proceed with his off-label promotion suit against Pfizer, but he must show the company engaged in unlawful kickbacks, a federal judge ruled
You may also be interested in...
Qui Tam Litigation: Peter Rost Suit Fails As Others Thrive
While whistleblowers have been scoring big payouts in suits alleging off-label promotion and kickbacks, Peter Rost struck out in his seven-year suit against Pfizer.
Qui Tam Litigation: Peter Rost Suit Fails As Others Thrive
While whistleblowers have been scoring big payouts in suits alleging off-label promotion and kickbacks, Peter Rost struck out in his seven-year suit against Pfizer.
Supreme Court To Decide If Whistle Blowers Can Sue Based On State Data
The pharma industry had reason to cheer when the Supreme Court announced the next round of cases it would take up. Missing from the June 22 order list was a suit challenging reverse settlements between brand and generic manufacturers